Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment-Reference-Cited by-同舟云学术

Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment

Published:2015-07-14 Issue:11 Volume:62 Page:1956-1961
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Lê Phu Quoc¹,Gulbis Béatrice²,Dedeken Laurence¹,Dupont Sophie³,Vanderfaeillie Anna⁴,Heijmans Catherine¹⁵,Huybrechts Sophie¹,Devalck Christine¹,Efira André⁶,Dresse Marie-Françoise⁷,Rozen Laurence⁸,Benghiat Fleur Samantha⁹,Ferster Alina¹

Affiliation:

1. Hemato-Oncology Unit, Hôpital Universitaire des Enfants Reine Fabiola; U.L.B.; Brussels Belgium

2. Department of Clinical Chemistry, Hôpital Erasme; U.L.B.; Brussels Belgium

3. Hemato-Oncology Unit; Cliniques Universitaires Saint Luc; Brussels Belgium

4. Department of Pediatrics, Hôpital Saint-Pierre; U.L.B.; Brussels Belgium

5. Department of Pediatrics; Hôpital de Jolimont; La Louvière Belgium

6. Hemato-Oncology Unit, Hôpital Universitaire Brugmann; U.L.B.; Brussels Belgium

7. Hemato-Oncology Unit, Hôpital Régional de la Citadelle; ULg; Liège Belgium

8. Laboratory of Hematology, CHU-Brugmann, Hôpital Universitaire des Enfants Reine Fabiola; U.L.B.; Brussels Belgium

9. Hemato-Oncology Unit, Hôpital Erasme; U.L.B.; Brussels Belgium

Funder

Fonds IRIS-Recherche Brussels